All In MedTech

Device Trial Radar · NCT01474889

Glucose Counterregulation in Long Standing Type 1 Diabetes

Effect of Real-Time Continuous Glucose Monitoring on Glucose Counterregulation in Long Standing Type 1 Diabetes

Last checked: Nov 19, 2026Latest source record: Aug 31, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

37

Actual

Start

Oct 2011

Primary completion

May 2016

Study completion Mar 5, 2021

Sponsor

Lead sponsor
University of PennsylvaniaAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
First posted
Nov 18, 2011

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Other
Who can join
All sexes, from 25 years, up to 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Enrollment for this study is complete. This study is designed to determine if use of a real-time continuous glucose monitor (RT-CGM) can reverse defective Glucose counter regulation and hypoglycemia unawareness in long standing type 1 diabetes.

Conditions

  • Hypoglycemia Unawareness
  • Type 1 Diabetes
  • Healthy

Interventions

  • RT-CGMDevice

    Each device is approximately the size of a pager and transmits with a subcutaneously placed sensor consisting of a 21 - 26 gauge needle 5 - 12 mm in length. Sensors are placed using sterile precautions and changed every 3 - 7 days depending on the manufacturers' instructions. All devices are approved as adjunctive tools to blood glucose monitoring that will be continued at least 4 times daily, before each meal and at bedtime.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Endogenous Glucose ProductionTime frame: 6 months

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • Clinical and Translational Research Center, Hospital of University of Pennsylvania

    Philadelphia, Pennsylvania

  • Rodebaugh Diabetes Center, University of Pennsylvania

    Philadelphia, Pennsylvania

  • University of Pennsylvania - Institute for Diabetes, Obesity and Metabolism

    Philadelphia, Pennsylvania

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.